Cancer Genet Cytogenet 2003, 144: 44–51.PubMedCrossRef 16. Kawashima H, Ogose A, Gu W, Nishio J, Kudo N, Kondo N, Hotta T, Umezu H, Tohyama T, Nishijima H, Iwasaki H, Endo N: Establishment and characterization of a novel myxofibrosarcoma cell line. Cancer Genet Cytogenet 2005, 161: 28–35.PubMedCrossRef 17. Hakozaki M, Hojo H, Sato M, Tajino T, Yamada H, Kikuchi S, Abe M: learn more Establishment and characterization of a
new cell line, FPS-1, derived from human undifferentiated pleomorphic sarcoma, overexpressing epidermal growth factor receptor and cyclooxygenase-2. Anticancer Res 2006, 26: 3393–3402.PubMed 18. Shaffer LG, Slovak ML, Campbell LJ: ISCN. An international system for human cytogenetic nomenclature. Basel: Karger 2009. 19. Ishiguro M, Iwasaki H, Takeshita M, Hirose Y, Kaneko Y: A cyotogetic analyses in two cases of malignant peripheral nerve sheath tumor showing hypodiploid karyotype. Oncol Rep 2006, 16: 225–232.PubMed 20. Nishio J, Althof PA, Bailey JM, Zhou M, Neff JR, Barr FG, Parham DM, Teot L, Qualman SJ, Bridge JA: Use of a novel FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of alveolar rhabdomyosarcoma. Lab Invest
2006, 86: 547–556.PubMed 21. Nishio J, Iwasaki H, Ohjimi Y, Ishiguro M, Isayama T, Naito M, Iwashita A, Kikuchi M: Overrepresentation of 17q22-qter and 22q13 in dermatofibrosarcoma protuberans but not in dermatofibroma: a comparative genomic hybridization study. Cancer Genet Cytogenet 2002, 132: 102–108.PubMedCrossRef 22. Iwasaki H, Nabeshima PD184352 (CI-1040) K, Nishio J, Jimi S, Aoki M, Koga K, Hamasaki M, Hayashi H, Mogi PARP activity A: Pathology of soft-tissue tumors: daily diagnosis, molecular cytogenetics and experimental
approach. Pathol Int 2009, 59: 501–521.PubMedCrossRef 23. Rydholm A, Mandahl N, Heim S, Kreicbergs A, Willen H, Mitelman F: Malignant Selleck Q-VD-Oph fibrous histiocytoma with a 19p+ marker chromosome have increased relapse rate. Genes Chromosomes Cancer 1990, 2: 296–299.PubMedCrossRef 24. Choong PFM, Mandahl N, Mertens F, Willen H, Alvegard T, Kreicbergs A, Mitelman F, Rydholm A: 19p+ marker chromosome correlates with relapse in malignant fibrous histiocytoma. Genes Chromosomes Cancer 1996, 16: 88–93.PubMedCrossRef 25. Schmidt H, Körber S, Hinze R, Taubert H, Meye A, Würl P, Holzhausen HJ, Dralle H, Rath FW: Cytogenetic characterization of ten malignant fibrous histiocytomas. Cancer Genet Cytogenet 1998, 100: 134–142.PubMedCrossRef 26. Larramendy ML, Tarkkanen M, Blomqvist C, Virolainen M, Wiklund T, Asko-Seljavaara S, Elomaa I, Knuutila S: Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker. Am J Pathol 1997, 151: 1153–1161.PubMed 27. Mairal A, Terrier P, Chibon F, Sastre X, Lecesne A, Aurias A: Loss of chromosome 13 is the most frequent genomic imbalance in malignant fibrous histiocytomas.